Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
10/2003
10/22/2003CN1125060C C-10 taxane derivatives and pharmaceutical compositions containing them
10/21/2003CA2210972C Isolation and purification of paclitaxel and cephalomannine
10/15/2003EP1352900A1 Process to prepare taxol
10/15/2003EP1352899A1 Process to prepare taxol
10/15/2003EP1351916A2 Ether compounds and compositions for cholesterol management and related uses
10/15/2003EP0975370B1 Composition and method for enhancing transport across biological membranes
10/15/2003CN1448128A Process for producing nanoparticles of paclitaxel and albumin
10/14/2003CA2162128C Quaternary ammonium and waterproofing/preservative compositions
10/09/2003WO2002067928A3 Metronomic dosing of taxanes for inhibiting tumor growth
10/09/2003US20030190687 Interacts with human DR5 to produce agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis; used to treat apoptosis-related disease and unregulated cell growth
10/08/2003EP0898557B9 Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates
10/08/2003CN1446626A Catalyst uitlized for preparing propylene oxide in one-step oxidation of propylene gas phase and its preparation method
10/08/2003CN1123569C Method of initially separating taxad alcohol from yew plant cell culturing liquid
10/07/2003US6630609 Taxane synthesis method and intermediates
10/02/2003WO2003080587A1 Labelled taxanes
10/02/2003US20030187061 Antitumor agnets; antileukemia agents
10/02/2003US20030185894 Process for producing nanoparticles of paclitaxel and albumin
10/02/2003CA2479273A1 Labelled taxanes
10/01/2003EP1348431A1 Process for producing nanoparticles of paclitaxel and albumin
10/01/2003EP1347984A2 A process for the preparation of taxan derivatives
10/01/2003EP0847393B1 Paclitaxel synthesis from precursor compounds and methods of producing the same
10/01/2003CN1446207A Process for preparation of baccatin Ôàó derivatives
09/2003
09/29/2003CA2423915A1 Process for producing nanoparticles of paclitaxel and albumin
09/25/2003WO2002030884A3 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
09/25/2003WO2002030882A3 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
09/25/2003US20030181737 Supercritical extraction of taxanes
09/24/2003EP1011329B1 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
09/24/2003EP0876362B1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
09/23/2003US6624317 Taxoid conjugates as antimitotic and antitumor agents
09/18/2003US20030176361 Having cytoprotective activity and protective activity for neuroinflammation, and neurodegenerative disorders; for use in therapy of stroke, cerebral ischemia, myocardial infarction, myocardial ischemia, chronic heart failure, inflammation
09/17/2003EP1343477A2 Treatment of inoperable tumors by stereotactic injection of microspheres
09/17/2003EP0668762B1 Isobutenyl-substituted taxanes and their pharmaceutical compositions
09/17/2003CN1443209A Material that can be structured, method for producing same and their use
09/17/2003CN1442413A Method of extracting medical taxadol and its derivative using regenerable resources
09/16/2003US6620950 Starting from various bicyclo(5.3.1)undec-10-ene compounds of given formula having protected hydroxyl groups; use as antitumor agents
09/16/2003CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures
09/11/2003US20030171602 Enantioselective process
09/10/2003EP1140884B1 Process for production of an oxetane
09/10/2003CN1440967A Method for synthesizing alkohol of Chinese yew
09/09/2003CA2146372C New process for the esterification of baccatine iii and 10-desacetylbaccatine iii
09/03/2003EP1339703A1 A process for the preparation of paclitaxel
09/03/2003CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof
09/03/2003CN1120161C Partially synthetic taxinane with antineoplastic activity
09/02/2003US6613900 Cephalotaxane derivatives and process for their preparation
08/2003
08/28/2003US20030162971 Pentacyclic compound
08/28/2003US20030162961 Catalytic carbonylation of three and four membered heterocycles
08/28/2003US20030162719 Immobilization of active materials
08/27/2003EP1337602A1 Polymerizable liquid crystalline dioxetanes, their preparation and use
08/27/2003EP1070057B1 Use of 7-acyltaxols for the treatment of multidrug resistant cells
08/26/2003US6610878 Poly(3-cyclopropyl-3-hydroxypropionate) and processes for its preparation and derivatives thereof
08/26/2003US6610860 C7 ester substituted taxanes
08/21/2003US20030158425 Produced from butyrolactone and valerolactone by addition of formaldehyde in supercritical fluid in presence of catalyst and phase transfer agent
08/21/2003US20030158423 Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
08/21/2003US20030158422 Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
08/21/2003US20030158373 For making A fluorinated polyetherurethane copolymer elastomer; TEFLON similar nonstick coatings, hydrophobic, low surface energies, low glass transition temperatures, nonabrasive and tear strength, adhesion
08/21/2003US20030158249 Is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1 mu M.
08/20/2003EP1335910A1 Isolation of taxanes
08/20/2003CN1437473A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
08/19/2003CA2072400C Supercritical extraction of taxanes
08/14/2003US20030153544 Fatty acid derivatives
08/12/2003US6605595 Higher antiparasitic activity
08/07/2003WO2003064423A1 Aza-arylpiperazines
08/07/2003WO2003064403A1 Furanone derivatives
08/07/2003US20030149284 Forming 7-O-methylthiomethyl paclitaxel by reacting paclitaxel with butyldimethylsilyl chloride; anticancer/antitumor agents
08/07/2003US20030149095 Preparation of orlistat and orlistat crystalline forms
08/07/2003CA2474871A1 Furanone derivatives
08/06/2003EP1117440B1 Pharmaceutical compositions containing paclitaxel
07/2003
07/31/2003WO2002030863A3 Ether compounds and compositions for cholesterol management and related uses
07/31/2003US20030144344 Use as anti-tumor agents; examples of solvents are N-methyl-2-pyrrolidone and acetonitrile
07/24/2003WO2003016543A3 Enzymatic resolution of t-butyl taxane derivatives
07/24/2003US20030138919 Fermentation process for lipstatin and method of extracting lipstatin from a fermentation broth
07/22/2003US6596880 Esterification of baccatine derivative
07/22/2003US6596757 Taxanes linked to a cell binding agent. A therapeutic composition for killing selected cell populations comprising: (A) a cytotoxic amount of one or more polyethylene glycol-containing taxanes covalently bonded to a cell binding
07/22/2003US6596737 C10 carbamoyloxy substituted taxanes
07/22/2003US6596518 Culture product; lipase inhibitor
07/17/2003WO2003057685A1 Luminacin analogs and uses thereof
07/17/2003WO2003057683A1 Methylenelactone synthesis in supercritical fluids
07/17/2003WO2003057250A1 Cancer treatment
07/17/2003WO2003057208A1 Taxane based compositions and methods of use
07/17/2003CA2472893A1 Cancer treatment
07/17/2003CA2471572A1 Taxane based compositions and methods of use
07/16/2003EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses
07/15/2003US6593482 Methods for preparing new taxoids and pharmaceutical compositions containing them
07/15/2003US6593479 Coating composition comprising a bicyclo- or spiro-orthoester functional compound
07/15/2003US6592894 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
07/10/2003WO2003039437A3 Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel
07/10/2003WO2003032908A3 Novel prodrugs of n-h bond-containing compounds and methods of making thereof
07/09/2003CN1429225A C10 carbonate substituted taxanes as antitumor agents
07/09/2003CN1428338A Semi-synthesis method of taxol
07/09/2003CN1428337A Method for synthesizing taxol C-13 side chain precursor
07/09/2003CN1113881C 8-substituted-1,3,8-triaza-spiro [4.5] decan-4-on derivatives
07/08/2003US6589979 Derivatives of seco-baccatine III, with bioavailability through the oral route, reduced toxicity and high antiangiogenetic activity; use as antiarthritic agent as well
07/02/2003EP1322302A2 Taxoid conjugates as antimitotic and antitumor agents
07/02/2003CN1427002A Method of preparing taxadol from leaf and twing of planted taxus chinensis
06/2003
06/26/2003WO2003051824A1 α-CYANOACRYLATES
06/26/2003US20030120096 Reacting racemic beta-lactam with lithium- 7-protected baccatin III- complex to form 3'desphenyl-3'-(1-napthyl)taxol; antitumor agents
06/26/2003US20030119914 Bis(thio-hydrazide amide) compounds; anticancer agents
06/26/2003US20030119814 Novel prodrugs of N-H bond-containing compounds and methods of making thereof
06/26/2003CA2469716A1 .alpha.-cyanoacrylates
06/25/2003EP0673372B1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 55